eClinical solutions Market Size By Solution, By Delivery Mode, By Clinical Trial Phase, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023

Description

List of Tables

eClinical Solutions Market is expected to grow exponentially through 2032, owing to the increasing R&D expenditure on innovative drug development. Besides, the rising clinical trials funded by various governmental bodies would offer lucrative growth prospects to the market over 2023-2032.

Additionally, the growing investments in R&D, new product launches, mergers, acquisitions, and partnerships by leading eClinical solution providers will enable the behemoths to strengthen their presence in the marketplace. To cite an instance, in 2021, Advarra, the market leader in regulatory review solutions, research quality, compliance consulting services, and clinical site-centric technologies, announced the acquisition of Bio-Optronics, maker of CCTrialSuite. The latest move would enable the clientele of both the firms to continue receiving superior quality service and enhanced benefits offered by the combined entity.

Overall, the eClinical solutions industry is segmented in terms of solution, delivery mode, clinical trial phase, end-use, and region.

Considering the solution, the clinical data management system (CDMS) segment will depict considerable CAGR during the forecast years. The CDMS helps control data entry, storage, and transmission; generate acceptable clinical research results and compliant submissions; verify the data are of the highest quality; and empower better patient experiences and outcomes by reducing drug development and fast-tracking a drug's time-to-market.

Based on delivery mode, the licensed enterprise (on-premises) solutions segment is projected to record significant returns throughout 2023-2032. Licensed enterprise solutions offer complete ownership and control to the end-user organizations for any configurations, changes, and upgrades in the solution, which is anticipated to infuse its adoption in the foreseeable years.

In terms of the clinical trial phase, the phase I segment will depict over 10% CAGR through 2032. The surging number of phase I trials to determine the drug's safety, pharmacokinetics, pharmacodynamics, and tolerability in the human body will support the segmental growth in the coming years.

By end-use, the CROs (contract research organizations) held 39.5% market share in 2022. Increasing demand for outsourcing clinical trials to various CROs, in an attempt to reduce the R&D expenses of pharma and biotech companies, will amplify the demand for contract research organizations.

Regionally, the North America eClinical solution industry held over 48% market share in 2022. The increasing presence of leading pharma and medical devices firms in the region is slated to positively influence the market landscape throughout the foreseeable period. Besides, the availability of sophisticated infrastructure, constant innovations of new products, and investments by the government are some of the key factors estimated to drive product demand across the region.

Product Code: 1774

Chapter 1 Methodology & Scope

1.1 Market scope and definition
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 eClinical solutions industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Solution trends
- 2.1.3 Delivery mode trends
- 2.1.4 Clinical trial phase trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends

Chapter 3 eClinical Solutions Industry Insights

3.1 Industry segmentation
3.2 Industry landscape
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Rise in government funding grants for clinical trials
  - 3.3.1.2 Growing demand for outsourcing clinical trials to CROs
  - 3.3.1.3 Increasing adoption of software solutions in clinical trials
  - 3.3.1.4 Increasing R&D expenditure across the globe
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 High implantation cost
  - 3.3.2.2 Low adoption and lack of awareness pertaining to eClinical solutions in developing countries
3.4 Growth potential analysis
- 3.4.1 By solution
- 3.4.2 By delivery mode
- 3.4.3 By clinical trial phase
- 3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Software landscape
3.7 Regulatory landscape
- 3.7.1 U.S.
- 3.7.2 Europe
- 3.7.3 China
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis
4.3 Company positioning matrix
4.4 Strategic dashboard

Chapter 5 eClinical Solutions Market, By Solution

5.1 Key solution trends
5.2 Randomization & trial supply management (RTSM)
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Clinical data management system (CDMS)
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Clinical trial management system (CTMS)
- 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Electronic clinical outcome assessment (eCOA)
- 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Electronic trial master file (eTMF)
- 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7 Electronic data capture (EDC)
- 5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.8 Others
- 5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 eClinical Solutions Market, By Delivery Mode

6.1 Key delivery mode trends
6.2 Licensed enterprise (on-premise) solution (LES)
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Cloud-based (SAAS) solution (CBS)
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Web-hosted (on-demand) solution (WHS)
- 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 eClinical Solutions Market, By Clinical Trial Phase

7.1 Key clinical trial phase trends
7.2 Phase I
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Phase II
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Phase III
- 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Phase IV
- 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 eClinical Solutions Market, By End-use

8.1 Key end-use trends
8.2 Contract research organization (CROs)
- 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Medical device companies
- 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Pharma/biotech companies
- 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Hospitals & clinics
- 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.6 Others
- 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 eClinical Solutions Market, By Region

9.1 Key regional trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Poland
- 9.3.7 Switzerland
- 9.3.8 Netherland
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Indonesia
- 9.4.7 Thailand
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Chile
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Egypt

Chapter 10 Company Profiles

10.1 Bio-optronics
10.2 Signant Health (CRF Health)
10.3 Datatrak, Inc
10.4 Clario
10.5 Veeva Systems
10.6 IBM Watson Health (Merge Healthcare Inc)
10.7 Oracle Corporation
10.8 Anju Software Inc (OmniComm System Inc)
10.9 Parexel International Corporation
10.10 Acralyon
10.11 Ennov
10.12 OpenClinica LLC
10.13 Medsharing
10.14 Multihealth Group (Clinfile)
10.15 Dassault Systemes (Medidata)
10.16 Arone (Invarture Group)
10.17 ALTENE Group (Axial)
10.18 Datacapt
10.19 Evamed